MW185A1 - 1,3-disubstituted oxindoles as analgesic and anti-inflammatory agents - Google Patents
1,3-disubstituted oxindoles as analgesic and anti-inflammatory agentsInfo
- Publication number
- MW185A1 MW185A1 MW1/85A MW185A MW185A1 MW 185 A1 MW185 A1 MW 185A1 MW 1/85 A MW1/85 A MW 1/85A MW 185 A MW185 A MW 185A MW 185 A1 MW185 A1 MW 185A1
- Authority
- MW
- MALAWI
- Prior art keywords
- analgesic
- inflammatory agents
- oxindoles
- disubstituted
- disubstituted oxindoles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57790384A | 1984-02-07 | 1984-02-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MW185A1 true MW185A1 (en) | 1986-04-09 |
Family
ID=24310612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MW1/85A MW185A1 (en) | 1984-02-07 | 1985-02-05 | 1,3-disubstituted oxindoles as analgesic and anti-inflammatory agents |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4658037A (no) |
| JP (1) | JPS60248669A (no) |
| KR (2) | KR880000433B1 (no) |
| BG (3) | BG40963A3 (no) |
| CS (1) | CS252480B2 (no) |
| DD (2) | DD234417A5 (no) |
| HU (1) | HU194166B (no) |
| IN (1) | IN163263B (no) |
| MW (1) | MW185A1 (no) |
| PL (3) | PL145230B1 (no) |
| RO (2) | RO90621A2 (no) |
| YU (3) | YU43866B (no) |
| ZA (1) | ZA85888B (no) |
| ZM (1) | ZM785A1 (no) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4721712A (en) * | 1984-06-12 | 1988-01-26 | Pfizer Inc. | 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents |
| US4808601A (en) * | 1984-09-19 | 1989-02-28 | Pfizer Inc. | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds |
| US4752609A (en) * | 1985-06-20 | 1988-06-21 | Pfizer Inc. | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds |
| WO1990008145A1 (en) * | 1989-01-10 | 1990-07-26 | Pfizer Inc. | Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles |
| US5086186A (en) * | 1989-05-25 | 1992-02-04 | Pfizer Inc. | N-trichloroacetyl-2-oxindole-1-carboxamides |
| US4952703A (en) * | 1989-05-25 | 1990-08-28 | Pfizer Inc. | Intermediates for making 2-oxindole-1-carboxamides |
| US5298522A (en) * | 1993-01-22 | 1994-03-29 | Pfizer Inc. | 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio |
| ES2097025T3 (es) * | 1993-02-09 | 1997-03-16 | Pfizer | Oxindol 1-(n-(alcoxicarbonil))carboxamidas y 1-(n-carboxamido)carboxamidas como agentes antiinflamatorios. |
| AU2002322720B2 (en) | 2001-07-25 | 2008-11-13 | Raptor Pharmaceutical Inc. | Compositions and methods for modulating blood-brain barrier transport |
| WO2006116718A2 (en) | 2005-04-28 | 2006-11-02 | Proteus Biomedical, Inc. | Pharma-informatics system |
| JP2010503710A (ja) | 2006-09-18 | 2010-02-04 | ラプトール ファーマシューティカル インコーポレイテッド | 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置 |
| JP2009040790A (ja) * | 2008-08-29 | 2009-02-26 | Ube Ind Ltd | ５−フルオロオキシインドールの製造法 |
| ES2919563T3 (es) | 2009-02-20 | 2022-07-27 | Enhanx Biopharm Inc | Sistema de administración de medicamentos a base de glutatión |
| EA024559B1 (ru) | 2009-05-06 | 2016-09-30 | Лаборэтори Скин Кэа, Инк. | Композиции для нанесения на кератинизированную поверхность кожи млекопитающего и способ доставки |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
| CN103570604B (zh) * | 2012-07-21 | 2015-10-07 | 重庆圣华曦药业股份有限公司 | 齐拉西酮中间体的合成方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3462450A (en) * | 1966-06-29 | 1969-08-19 | Merck & Co Inc | Chemical compounds |
| GB1158532A (en) * | 1967-01-05 | 1969-07-16 | Centre Nat Rech Scient | 2-Oxoindoline-3-Carboxylic Acids and Esters thereof |
| US3631177A (en) * | 1967-04-18 | 1971-12-28 | Smith Kline French Lab | 3-phenacyl-2-oxoindolines |
| US3519592A (en) * | 1967-04-18 | 1970-07-07 | Smithkline Corp | Indole compounds |
| BE714717A (no) * | 1967-05-12 | 1968-09-30 | ||
| FR7337M (no) * | 1968-01-11 | 1969-10-13 | ||
| BE756447A (fr) * | 1969-10-15 | 1971-03-22 | Pfizer | Oxindolecarboxamides |
| US3749731A (en) * | 1971-07-08 | 1973-07-31 | Warner Lambert Co | 2-oxo-n-(2-thiazolyl)-3-indoline-carboxamide |
| US3975531A (en) * | 1973-10-02 | 1976-08-17 | A. H. Robins Company, Incorporated | 4-(5- And 7-)benzoylindolin-2-ones and pharmaceutical uses thereof |
| US4221716A (en) * | 1979-02-16 | 1980-09-09 | A. H. Robins Company, Inc. | Intermediate and process for the preparation of 7-acylindolin-2-ones |
-
1985
- 1985-01-22 IN IN42/DEL/85A patent/IN163263B/en unknown
- 1985-02-04 RO RO85117533A patent/RO90621A2/ro unknown
- 1985-02-04 RO RO121802A patent/RO93218B/ro unknown
- 1985-02-05 KR KR1019850000714A patent/KR880000433B1/ko not_active IP Right Cessation
- 1985-02-05 MW MW1/85A patent/MW185A1/xx unknown
- 1985-02-05 CS CS85785A patent/CS252480B2/cs unknown
- 1985-02-05 ZM ZM7/85A patent/ZM785A1/xx unknown
- 1985-02-06 DD DD85273087A patent/DD234417A5/de not_active IP Right Cessation
- 1985-02-06 BG BG068717A patent/BG40963A3/xx unknown
- 1985-02-06 BG BG072172A patent/BG43865A3/xx unknown
- 1985-02-06 BG BG072170A patent/BG44204A3/xx unknown
- 1985-02-06 JP JP60020163A patent/JPS60248669A/ja active Granted
- 1985-02-06 HU HU854686A patent/HU194166B/hu unknown
- 1985-02-06 ZA ZA85888A patent/ZA85888B/xx unknown
- 1985-02-06 YU YU180/85A patent/YU43866B/xx unknown
- 1985-02-07 PL PL1985255466A patent/PL145230B1/pl unknown
- 1985-02-07 PL PL1985251869A patent/PL145196B1/pl unknown
- 1985-02-07 PL PL1985255465A patent/PL145310B1/pl unknown
- 1985-12-30 US US06/814,719 patent/US4658037A/en not_active Expired - Lifetime
-
1986
- 1986-04-01 DD DD86288635A patent/DD244133A5/de not_active IP Right Cessation
-
1987
- 1987-04-10 KR KR1019870003430A patent/KR880000434B1/ko not_active IP Right Cessation
- 1987-07-09 YU YU129087A patent/YU46320B/sh unknown
- 1987-10-30 YU YU1981/87A patent/YU44062B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL255465A1 (en) | 1986-07-15 |
| CS78585A2 (en) | 1987-01-15 |
| KR850005824A (ko) | 1985-09-26 |
| RO93218B (ro) | 1988-01-01 |
| ZM785A1 (en) | 1985-08-22 |
| CS252480B2 (en) | 1987-09-17 |
| RO90621A2 (ro) | 1986-12-10 |
| YU198187A (en) | 1988-10-31 |
| DD244133A5 (de) | 1987-03-25 |
| US4658037A (en) | 1987-04-14 |
| KR880000434B1 (ko) | 1988-03-24 |
| HU194166B (en) | 1988-01-28 |
| PL145310B1 (en) | 1988-09-30 |
| PL145196B1 (en) | 1988-08-31 |
| JPH0413340B2 (no) | 1992-03-09 |
| RO93218A (ro) | 1987-12-31 |
| BG43865A3 (en) | 1988-08-15 |
| KR880000433B1 (ko) | 1988-03-24 |
| DD234417A5 (de) | 1986-04-02 |
| YU18085A (en) | 1988-04-30 |
| PL251869A1 (en) | 1985-12-17 |
| BG44204A3 (en) | 1988-10-14 |
| YU46320B (sh) | 1993-05-28 |
| YU44062B (en) | 1990-02-28 |
| BG40963A3 (en) | 1987-03-14 |
| JPS60248669A (ja) | 1985-12-09 |
| YU129087A (en) | 1988-02-29 |
| IN163263B (no) | 1988-08-27 |
| ZA85888B (en) | 1986-09-24 |
| YU43866B (en) | 1989-12-31 |
| PL145230B1 (en) | 1988-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA856387B (en) | Analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives | |
| NZ210940A (en) | 1,2,3-trihydro-3-(1h-imidazol-1-ylmethyl)-4h-carbazol-4-one derivatives and pharmaceutical compositions | |
| AU556948B2 (en) | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds | |
| GB8521793D0 (en) | Analgesic & anti-inflammatory compositions | |
| MW185A1 (en) | 1,3-disubstituted oxindoles as analgesic and anti-inflammatory agents | |
| PH21862A (en) | Indoline and 2 indoline derivatives | |
| ZA865019B (en) | 1-substituted oxindole-3-carboxamides as antiinflammatory and analgesic agents | |
| ZA853379B (en) | Substituted 1-oxa-dethiachphalosporins as anti-inflammatory and antidegenerative agents | |
| ZA851521B (en) | Phenylthiomethyl-6-hydroxy-2,3-dihydrobenzo-pyran and analogs thereof useful as anti-inflammatory agents | |
| NZ214088A (en) | 1,3-diazoles and pharmaceutical compositions | |
| ZA854947B (en) | Beta-lactam derivatives as anti-inflammatory and anti-degenerative agents | |
| ZM1185A1 (en) | 3-substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents | |
| IT1200931B (it) | Derivativi triazinici dotati di attivita' analgesica,antipiretica ed antiinfiammatoria | |
| NZ218441A (en) | 1-phenoxy-2-propanol derivatives and antihypertensive compositions | |
| AU6548486A (en) | Dihydrobenzothiophene and thiochromane aminoalcohols | |
| PH20395A (en) | 1,3-disubstituted oxindoles as analgesic and anti-inflammatory agents | |
| MW1685A1 (en) | N,3-disubstituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents | |
| DE3261724D1 (en) | Analgesic and anti-inflammatory composition | |
| NZ213629A (en) | 4,4-diphenylpiperidine derivatives and pharmaceutical compositions | |
| ZM3185A1 (en) | N,3-disubstituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents | |
| DE3562372D1 (en) | Menthene sulphonates and the hydrogenated derivatives thereof | |
| GB2201591B (en) | Analgesic antipyretic and anti-inflammatory compositions. | |
| NZ218085A (en) | 5-heterocyclic-2,4-dialkyl-3h-1,2,4-triazole-3-thiones and pharmaceutical compositions | |
| GB2150134B (en) | Pharmaceutically active 1,1-diphenyl-4-isobutylamino-1-1butanol and derivatives thereof | |
| NZ218084A (en) | 5-naphthyl-2,4-dialkyl-3h-1,2,4-triazole-3-thiones and pharmaceutical compositions |